SubsidieMeestersNew generation of substrates to harness the full power of microorganisms
Bac3Gel develops advanced 3D substrates to cultivate complex microbial communities, aiming to discover new antibiotics and bio-based solutions for health and industry challenges.
Projectdetails
Introduction
Bac3Gel is a biotech company that develops and distributes advanced substrates to harness the full power of microorganisms.
Innovative Substrates
Bac3Gel substrates are the first that combine three-dimensionality with gradients of oxygen, nutrients, and physical properties. This unique combination allows the growth of complex microbial communities and currently unculturable bacteria that depend on these microenvironments to thrive.
Impact on Microbiology
Our advanced substrates have the power to revolutionize the status quo of microbiology and unlock innovative bacteria-based solutions to solve challenges across multiple bio-based industries.
Mission
Bac3Gel's mission is to ultimately foster the discovery of new antibiotics and bio-based solutions to feed the ever-growing demand for innovative treatments. Additionally, we aim to develop microbiome-modulating drugs to address 90% of diseases linked to human microbiome imbalance.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 1.500.712 |
| Totale projectbegroting | € 2.143.875 |
Tijdlijn
| Startdatum | 1-7-2023 |
| Einddatum | 30-6-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- BAC3GEL, LDA.penvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
SBMP - disrupting the manufacturing of biological drugs through a ground-breaking nanotechnology-based microcarrierCellevate's SBMP-microcarriers use innovative nanofibrous technology to enhance adherent cell culture in bioreactors, significantly improving biopharmaceutical production efficiency and quality. | EIC Accelerator | € 2.485.857 | 2022 | Details |
AgroBiogel International Scale-upAgrobiogel is an innovative soil improver that enhances water retention, reduces costs, and transforms non-productive soils while utilizing underused lignin to promote sustainability in agriculture. | EIC Accelerator | € 2.384.900 | 2022 | Details |
Scalable and Eco-friendly BioproductionCore Biogenesis aims to become the European leader in plant-based biomanufacturing by 2025, using a novel process to significantly enhance yield and reduce costs for producing pharmaceutical proteins. | EIC Accelerator | € 1.153.390 | 2023 | Details |
SBMP - disrupting the manufacturing of biological drugs through a ground-breaking nanotechnology-based microcarrier
Cellevate's SBMP-microcarriers use innovative nanofibrous technology to enhance adherent cell culture in bioreactors, significantly improving biopharmaceutical production efficiency and quality.
AgroBiogel International Scale-up
Agrobiogel is an innovative soil improver that enhances water retention, reduces costs, and transforms non-productive soils while utilizing underused lignin to promote sustainability in agriculture.
Scalable and Eco-friendly Bioproduction
Core Biogenesis aims to become the European leader in plant-based biomanufacturing by 2025, using a novel process to significantly enhance yield and reduce costs for producing pharmaceutical proteins.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
DittoEV Biotech en SG Papertronics ontwikkelen in het DITTO-project een goedkoop, real-time monitoring apparaat voor het optimaliseren van bacteriën die bioplastics produceren. | Mkb-innovati... | € 175.033 | 2020 | Details |
Harnessing Specialized Metabolism from AnaerobesThe AnoxyGen project aims to explore and harness the unique biosynthetic capabilities of anaerobic bacteria to discover novel metabolites and enhance biotechnological applications for health and ecology. | ERC Advanced... | € 2.499.859 | 2025 | Details |
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demandThis project aims to unlock the expression of cryptic biosynthetic gene clusters in Streptomyces to enhance drug discovery and agricultural applications through innovative systems biology and ecological insights. | ERC Advanced... | € 3.343.206 | 2022 | Details |
Microbial Synthetic in vivo Cell Therapy SystemsThe MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways. | ERC Starting... | € 1.499.938 | 2023 | Details |
Genetisch gemodificeerde micro-organismen op een bio-based dieetEV Biotech onderzoekt de haalbaarheid van genetisch gemodificeerde micro-organismen die zetmeel kunnen afbreken voor duurzame biomolecuulproductie, ter vervanging van dure glucose. | Mkb-innovati... | € 20.000 | 2023 | Details |
Ditto
EV Biotech en SG Papertronics ontwikkelen in het DITTO-project een goedkoop, real-time monitoring apparaat voor het optimaliseren van bacteriën die bioplastics produceren.
Harnessing Specialized Metabolism from Anaerobes
The AnoxyGen project aims to explore and harness the unique biosynthetic capabilities of anaerobic bacteria to discover novel metabolites and enhance biotechnological applications for health and ecology.
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demand
This project aims to unlock the expression of cryptic biosynthetic gene clusters in Streptomyces to enhance drug discovery and agricultural applications through innovative systems biology and ecological insights.
Microbial Synthetic in vivo Cell Therapy Systems
The MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways.
Genetisch gemodificeerde micro-organismen op een bio-based dieet
EV Biotech onderzoekt de haalbaarheid van genetisch gemodificeerde micro-organismen die zetmeel kunnen afbreken voor duurzame biomolecuulproductie, ter vervanging van dure glucose.